Welcome to Mesh Medical Device News Desk (MND)
Putting a Face on Adverse Events
I hope you find this a helpful resource.
I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.
Patients receiving the same product for hernia repairs are increasingly reporting the same complications. That’s where Mesh News Desk comes in.
The public has learned about mesh complications largely through law firm advertisements but the story behind the solicitations remains largely untold. “Putting a Face on Adverse Events” is the mission of MND and its role has expanded as more information becomes available.
The public is just now becoming aware that many medical devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an outdated FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.
Imagine a permanent medical device that does not undergo the same scrutiny as drugs! Even if that device cannot be removed. It defies common sense. I believe this is one of the most incredible public health issues of our day!
Mesh Medical Device News Desk is committed to providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that still appears to be under the radar of most major news organizations. Patients, women, men, citizens deserve to have comprehensive fact-based reporting on these devices and medical procedures so they can have truly informed consent.
MND vows to provide balanced reports produced with the highest professional journalistic standards, talking to all sides and to investigate issues behind the headlines concerning medical devices and surgical mesh. An appearance on this website should not be considered an endorsement.
Information that appears here is not intended to substitute for legal or medical advice from professionals. Also be forewarned, anything published can be subject to discovery demands for litigation so please thing twice before hitting a “send” key. Extremely personal information may be best shared with your legal and medical professionals. Please do not use your full name when commenting.
My Interest in FDA and Surgical Mesh
I first became acquainted with the issues in 2009 and produced a series for Injuryboard called, Suffering in Silence, Part 1-4 (here) where I interviewed many men and women who are suffering the effects of synthetic mesh used for hernia repair and female pelvic floor reconstruction. I myself have not received a pelvic mesh implant.
My Background – I have been a journalist for nearly 30 years working as a broadcaster, anchor and reporter at stations all around the country as well as CNN. I’ve won numerous awards including the Society of Professional Journalists Award for Ethics as well as the Goldman Prize, North America 2001 for environmental reporting. My then-husband and I challenged News Corp after it tried to suppress a story about synthetic bovine growth hormone (rBGH) used in much of the nation’s dairy supply. The litigation lasted eight years and included a jury award to me after a 5 week trial and an appeal of that decision.
BTW- the jury found that I was fired from Fox (News Corp) for threatening to report intention news distortion to the regulatory body, the Federal Communications Committee (FCC). The jury awarded me $425,000 but Fox immediately appealed. A three-judge panel overturned the victory and then Fox came after us for court costs. Ultimately we had to pay them some of their costs.
I wrote about this in “Into the Buzzsaw“ available here.
Understanding the way the FDA approved rBGH is very similar to the way some medical devices slip through critical scrutiny by a federal regulatory system that sometimes feels more like the tail wagging the dog. Our story was told in the film, The Corporation, see a clip here.
This website is not a legal referral service and the information contained is not intended to substitute for advice from legal and medical professionals!
Your personal information or email will not be shared with anyone. Promise. Occasionally someone wants to reach out to someone else, but I always ask both parties before I serve as an intermediary. Your comments become the property of this website and your email may be used to enroll you in the Mesh Newsletter, an online update to the latest news mesh-related!
Ownership of the content on this website belongs to Independent News Group LLC, a multi-media communications company which belongs to your editor, Jane Akre. The material has a copyright and the material may not be shared without written permission. That includes Mesh News Desk, Mesh Medical Device News Desk and Mesh Device News (the twitter name). As a publisher, ING LLC is supported through advertising and donations.
Sponsored Content will be labeled as such so the reader can understand what comes from an advertiser! We always want our readers to be clearly informed. Thank you!
Readers should contact editor, Jane Akre, with any concerns, additions or corrections. Please be advised MND and its staff cannot handle your personal requests but we are all ears for any story ideas! Please feel free to visit the site’s Facebook page to post your questions to an audience and to reach out to Patient Advocates who for advice and direction. Hernia mesh questions are handled by Bruce Rosenberg, a patient advocate, who is also mesh injured. Text him at 954-701-5094. Mention my name.
Please feel free to contact me at firstname.lastname@example.org with any questions, story ideas, concerns or to discuss partnering opportunities. (904) 613-2828.
Thank you and please stay well!